Project Details
Short title | A Phase II multicentre trial of PF-03856884 (cvx-060), a selective angiopoietin-2 (ANG- 2) inhibitor in combination with axitinib in patients with previously treated metastatic renal cell carcinoma |
---|---|
Status | Finished |
Effective start/end date | 1/11/12 → 31/07/13 |
Funding
- Queen Elizabeth Hospital Birmingham